MA
MXCT icon

Mudita Advisors’s MaxCyte MXCT Stock Holding History

Mudita Advisors’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.15M Hold
3,370,689
– – 0.86% 19
2026
Q1 		$2.37M Hold
3,370,689
– – 0.48% 26
2025
Q4 		$5.22M Hold
3,370,689
– – 1.13% 18
2025
Q3 		$5.33M Hold
3,370,689
– – 1.54% 14
2025
Q2 		$7.35M Buy
3,370,689
+42,248
+1% +$102K 2.46% 14
2025
Q1 		$9.09M Buy
3,328,441
+105,034
+3% +$414K 4.59% 9
2024
Q4 		$13.4M Buy
3,223,407
+69,966
+2% +$264K 7.53% 5
2024
Q3 		$12.3M Buy
3,153,441
+167,101
+6% +$704K 6.71% 6
2024
Q2 		$11.7M Buy
2,986,340
+710,959
+31% +$3.06M 5.99% 7
2024
Q1 		$9.53M Buy
2,275,381
+394,032
+21% +$1.85M 5.68% 6
2023
Q4 		$8.84M Buy
1,881,349
+490,491
+35% +$1.91M 6.14% 7
2023
Q3 		$4.34M Buy
1,390,858
+561,200
+68% +$2.26M 3.17% 10
2023
Q2 		$3.81M Buy
829,658
+167,005
+25% +$767K 2.91% 14
2023
Q1 		$3.28M Buy
662,653
+572,452
+635% +$2.82M 2.94% 11
2022
Q4 		$492K Buy
90,201
+28,967
+47% +$178K 0.43% 18
2022
Q3 		$398K Buy
+61,234
New +$342K 0.37% 19

Other funds holding MXCT

CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $201M AUM 10.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BFM
Brooklands Fund Management London, United Kingdom $128M AUM
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Mudita Advisors's MXCT Position: Q2 2026 in Review

Mudita Advisors held its MaxCyte (MXCT) position steady in Q2 2026 at 3,370,689 shares worth $4.15M. The position accounts for 0.86% of the portfolio, ranked #19.

Mudita Advisors first reported a position in MXCT in Q3 2022 and has held it in 16 quarters since. The position peaked at $13.4M in Q4 2024. 123 funds tracked by Wall St. Rank hold MXCT as of Q2 2026.

  • Mudita Advisors held 3,370,689 shares of MaxCyte worth $4.15M as of Q2 2026.
  • Mudita Advisors left its MaxCyte share count unchanged in Q2 2026.
  • MaxCyte made up 0.86% of Mudita Advisors's portfolio in Q2 2026, its #19 holding.
  • Mudita Advisors first reported a position in MaxCyte in Q3 2022 and has held it in 16 quarters since.
  • Mudita Advisors's MaxCyte position peaked at $13.4M in Q4 2024.
  • 123 funds tracked by Wall St. Rank held MaxCyte as of Q2 2026.

Based on Mudita Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.